Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of revenue | $0 | $0 |
| Gross profit | $0 | $0 |
| Gross margin | — | — |
| R&D | $0 | $0 |
| Operating income | −$419 | −$1.8K |
| EBITDA | $334 | −$4.0M |
| Net income | −$85 | $442.2K |
| Net margin | — | — |
| EPS (diluted) | -0.00 | 0.04 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds GDNR.
No tracked institution reports a position in GDNR as of their last filing.
No one on the platform has traded GDNR yet.
| $5M |
| — |
| OTECOceanTech Acquisitions I Corp. | $11.75 | +0.43% | $41M | — |
| PBAXPhoenix Biotech Acquisition Corp. | $5.85 | +6.75% | $36M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.